OOIR: Observatory of International Research

Papers

(The H4-Index of Open Forum Infectious Diseases is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Monkeypox: A Contemporary Review for Healthcare Professionals	169
Long COVID and Post-infective Fatigue Syndrome: A Review	143
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19	123
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections	106
Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018	91
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study	84
Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms	83
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study	82
Coronavirus Disease 2019–Associated Invasive Fungal Infection	81
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients	80
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis	75
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States	72
Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism	72
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era	64
SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response	62
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement	60
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient—A Case Study	60
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants	59
Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19—United States, March–September 2020	59
Sexually Transmitted Infection Diagnoses and Access to a Sexual Health Service Before and After the National Lockdown for COVID-19 in Melbourne, Australia	57
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar	56
Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series	56
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	56
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response	54
Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients	54

The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network	54
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella mor	53
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease	53
Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies	51
The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries	51
Fungal Nomenclature: Managing Change is the Name of the Game	50
Economic Burden of Fungal Diseases in the United States	48
Social Determinants of Health and Care Outcomes Among People With HIV in the United States	48
Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study	48
The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study	48
Cefiderocol Activity Against ClinicalPseudomonas aeruginosaIsolates Exhibiting Ceftolozane-Tazobactam Resistance	46
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials	45
Persistent Symptoms in Patients Recovering From COVID-19 in Denmark	45
Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19	44
Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic	44
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine	44
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study	44
Factors Associated With Long COVID Symptoms in an Online Cohort Study	43
Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality	43